-
公开(公告)号:US20220288028A1
公开(公告)日:2022-09-15
申请号:US17613467
申请日:2020-05-29
IPC分类号: A61K31/41 , A61K31/4035 , A61P27/02 , A61K31/404 , A61K31/439 , A61K31/451 , A61K31/5377 , A61K45/06 , A61K9/00
摘要: Disclosed are methods of treating a non-infectious ocular immunoinflammatory disorder in a subject. Methods of reducing a symptom, e.g., ocular redness, of a non-infectious ocular immunoinflammatory disorder in a subject, and pharmaceutical composition containing an SP blocker, an SP antagonist, an SP receptor blocker or an SP receptor antagonist as an active component and a pharmaceutically acceptable carrier or excipient are also described.
-
公开(公告)号:US11306140B2
公开(公告)日:2022-04-19
申请号:US16068300
申请日:2017-01-06
发明人: Reza Dana , Sunil Chauhan , Yihe Chen
摘要: Methods and compositions for reducing the activity or number of memory Th17 cells in ocular tissue, and for treatment and/or prevention of ocular immunoinflammatory diseases are described.
-
公开(公告)号:US20190008765A1
公开(公告)日:2019-01-10
申请号:US16068300
申请日:2017-01-06
发明人: Reza Dana , Sunil Chauhan , Yihe Chen
摘要: Methods and compositions for reducing the activity or number of memory Th17 cells in ocular tissue, and for treatment and/or prevention of ocular immunoinflammatory diseases are described.
-
-